Notably, activation of NRF2 occurs in several malignancies through a variety of mechanisms, including mutations in KEAP1 or NRF2 that disrupt their interaction, epigenetic changes that influence NRF2 and KEAP1 expression, and chronic stress within the tumor microenvironment.49 This evidence concerns the gene NFE2L2 and neoplasm.